Improving Safety of Preemptive Therapy with Oral Valganciclovir for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation

Valganciclovir (VGC), an oral prodrug of ganciclovir (GCV), has been shown to clear cytomegalovirus (CMV) viremia in preemptive treatment of patients after allogeneic hematopoietic stem cell transplantation (alloHSCT), apparently without significant toxicity. Since VGC obviates hospitalization, it i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Barkam, Corinna, Kamal, Haytham, Dammann, Elke, Diedrich, Helmut, Buchholz, Stefanie, Eder, Matthias, Krauter, Jürgen, Ganser, Arnold, Stadler, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2012
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3518946/
https://ncbi.nlm.nih.gov/pubmed/23243512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/874601
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados